December 29, 2025 18:57 ET | Source: Mesoblast Limited Mesoblast has option to draw down up to US$125 million by…
DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive long-term safety results from its EXTEND study, a…
News Summary: The program has supported 250+ matters, with more than 19.2 million documents in Justice for Change workspaces. Access…
MILAN, July 17, 2025 /PRNewswire/ -- A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination…